Summaries
-
NICE guidelineNICE type 2 diabetes in children guideline
This succinct Guidelines summary advises on the appropriate diagnosis and management of type 2 diabetes mellitus in children and young people.
-
NICE guideline
NICE type 1 diabetes in children guideline
This summary includes recommendations on pharmacological therapy, and recognition and management of diabetic ketoacidosis.
-
NICE guideline
NICE type 1 diabetes guideline
This summary on type 1 diabetes in adults covers diagnosis, insulin therapy, and blood glucose management, and includes a useful algorithm
-
NICE guideline
NICE type 2 diabetes guideline
This updated summary provides recommendations on blood glucose targets, and includes a useful algorithm on blood glucose management
-
Independent professional body guideline
UKKA SGLT-2 inhibition in adults with kidney disease guideline
Covering the use of sodium–glucose co-transporter-2 inhibitors in the context of chronic kidney disease in adults
-
NICE guideline
NICE type 2 diabetes prevention guideline
This Guidelines summary covers the identification of people at high risk of type 2 diabetes and the provision of interventions for them
-
Independent professional body guideline
ABCD position on cardiovascular impact of glucose-lowering drugs
Key recommendations from the ABCD position statement on new glucose-lowering drugs concerning their cardiovascular impact on people with diabetes
-
Working party guideline/algorithm
Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd.
-
Independent professional body guideline
BSPID gum disease and diabetes guideline
A short overview of periodontal (gum disease) and its links with diabetes, including advice for community pharmacy teams
-
Independent professional body guideline
Type 2 diabetes pharmacological management pathway comparison
This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN
-
Independent professional body guideline
CaReMeUK cardiovascular risk optimisation algorithm
A guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease
-
NICE guideline
NICE diabetes in pregnancy guideline
An up-to-date summary of NICE guidance on diabetes management in pregnancy. Includes gestational diabetes, preconception, antenatal, and postnatal care.
-
Independent professional body guideline
KDIGO guideline on diabetes management in CKD
Recommendations on comprehensive care, glycaemic monitoring and targets, lifestyle and antihyperglycaemic interventions, and approaches to self-management and optimal models of care
-
Independent professional body guideline
PCDE pharmacological management of type 2 diabetes
This succinct summary highlights the treatment recommendations for type 2 diabetes by cardiovascular/renal disease or risk factor.
-
NICE guideline
Diabetic foot problems: prevention and management
This summary covers preventing and managing foot problems in children, young people, and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections
-
Working party guideline/algorithm
Guideline for the managed introduction of biosimilar basal insulin
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.
-
Independent professional body guideline
Type 2 diabetes: frailty in older people
Summary covers glycaemic targets for older people, priorities for improving high-quality diabetes care, and a useful frailty assessment pathway.
-
Working party guideline/algorithm
Pancreatic exocrine insufficiency guideline
This management algorithm was developed by a multidisciplinary expert panel: Hambling C et al with the support of a grant from Mylan Ltd.
-
SIGN guideline
SIGN type 2 diabetes guideline
This summary provides key recommendations on lifestyle management, treatment options, diabetic CVD, and CKD. Includes a useful treatment algorithm
![20210603 Guidelines comparison table [online]](https://d3j7puhwqgd8ts.cloudfront.net/Pictures/100x67/0/0/0/10000_20210603guidelinescomparisontableonline_766677.png)
